… thrombosis and pregnancy morbidity represent the clinical manifestations of antiphospholipid
syndrome … characterized by the persistent positivity of antiphospholipid antibodies (aPL). …

… vessel thrombosis is best described in the context of catastrophic antiphospholipid syndrome
… Small vessel thrombosis also occurs in the subacute/chronic setting, although the literature …

… positivity for antiphospholipid antibodies (aPL) is required to diagnose antiphospholipid
syndrome (APS), an autoimmune disease characterized by recurrent vascular thrombosis and/or …

… Research shows the central role of endothelial cells, monocytes, platelets, and complement
in induction of thrombosis and fetal death in antiphospholipid syndrome. Endothelial cells …

… antibody profile and on the presence of additional thrombotic risk factors. Current standard
treatment for unprovoked thrombosis is long-term warfarin or other vitamin K antagonist …

… APS can present with a variety of clinical phenotypes, including thrombosis in … thrombosis,
but other factors such as complement activation might be important. Prevention of thrombotic …

… RAPS is slightly larger than the two previous randomised controlled trials in patient with
thrombotic antiphospholipid syndrome, and our inclusion criteria enabled recruitment of a more …

… Finally, thrombosis in the antiphospholipid syndrome has been likened to that in heparin-induced
thrombocytopenia. Both syndromes induce thrombosis … , the site of thrombosis is often …

The antiphospholipid (aPL) antibody syndrome is an autoimmune condition in which vascular
thrombosis and/or recurrent pregnancy losses occur in patients with laboratory evidence …

… Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
occurrence of thrombosis (arterial and/or venous), often multiple, and/or morbidity in pregnancy (…